{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T13:27:14Z","timestamp":1774358834258,"version":"3.50.1"},"reference-count":8,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.3892\/ol.2015.3905","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T05:10:27Z","timestamp":1447132227000},"page":"231-233","source":"Crossref","is-referenced-by-count":11,"title":["Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report"],"prefix":"10.3892","volume":"11","author":[{"given":"KENTA","family":"KAWASAKI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YASUO","family":"HAMAMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MASAYUKI","family":"ADACHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKANORI","family":"KANAI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIROMASA","family":"TAKAISHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,11,10]]},"reference":[{"key":"key20180108095351_b1-ol-0-0-3905","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1200\/JCO.2008.16.2545","article-title":"Tumor cavitation: impact on objective response evaluation in trials of angiogenesis inhibitors in non-small-cell lung cancer","volume":"27","author":"Crabb","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20180108095351_b2-ol-0-0-3905","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1102\/1470-7330.2012.0027","article-title":"Tumoral cavitation in patients with non-small-cell lung cancer treated with antiangiogenic therapy using bevacizumab","volume":"12","author":"Nishino","year":"2012","journal-title":"Cancer Imaging"},{"key":"key20180108095351_b3-ol-0-0-3905","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/JTO.0b013e318168c7e9","article-title":"Tumor cavitation during therapy with antiangiogenesis agents in patients with lung cancer","volume":"3","author":"Marom","year":"2008","journal-title":"J Thorac Oncol"},{"key":"key20180108095351_b4-ol-0-0-3905","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(12)61900-X","article-title":"CORRECT Study Group: Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): An international, multicentre, randomised, placebo-controlled, phase 3 trial","volume":"381","author":"Grothey","year":"2013","journal-title":"Lancet"},{"key":"key20180108095351_b5-ol-0-0-3905","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0140-6736(13)60976-9","article-title":"Regorafenib for metastatic colorectal cancer","volume":"381","author":"Ricotta","year":"2013","journal-title":"Lancet"},{"key":"key20180108095351_b6-ol-0-0-3905","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1001\/jama.2009.1755","article-title":"Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases","volume":"302","author":"Chun","year":"2009","journal-title":"JAMA"},{"key":"key20180108095351_b7-ol-0-0-3905","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.lungcan.2007.01.022","article-title":"Bronchoscopy for bevacizumab-related hemoptysis","volume":"56","author":"Cho","year":"2007","journal-title":"Lung Cancer"},{"key":"key20180108095351_b8-ol-0-0-3905","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2045-3329-4-14","article-title":"Pneumothorax as adverse event in patients with lung metastases of soft tissue sarcoma treated with pazopanib: a single reference centre case series","volume":"4","author":"Verschoor","year":"2014","journal-title":"Clin Sarcoma Res"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2015.3905\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T06:41:27Z","timestamp":1515393687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2015.3905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,10]]},"references-count":8,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,11,10]]},"published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.3892\/ol.2015.3905"],"URL":"https:\/\/doi.org\/10.3892\/ol.2015.3905","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,10]]}}}